Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00832845
What this trial is testing

Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study

Who this might be right for
Schizophrenia
Centre for Addiction and Mental Health 80
Large-scale testing (Phase 3)Study completedNCT00145496
What this trial is testing

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)

Who this might be right for
Schizophrenia
Organon and Co 468
Not applicableStudy completedNCT04867447
What this trial is testing

Prevalence of Traumatic Events and PTSD in Immigrant and Non-immigrant Patients With Psychotic Disorder

Who this might be right for
Psychotic DisordersPsychological TraumaStress, Psychological+1 more
Parc de Salut Mar 199
Testing effectiveness (Phase 2)Ended earlyNCT03669640
What this trial is testing

Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 131
Testing effectiveness (Phase 2)Study completedNCT00401089
What this trial is testing

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderTardive Dyskinesia+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Post-approval studies (Phase 4)Study completedNCT00501618
What this trial is testing

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Manhattan Psychiatric Center 20
Not applicableLooking for participantsNCT05036590
What this trial is testing

Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.

Who this might be right for
Schizophrenia
Hôpital le Vinatier 206
Not applicableLooking for participantsNCT07701343
What this trial is testing

TACS for Working Memory in Schizophrenia

Who this might be right for
SchizophreniaWorking Memory
Central South University 30
Not applicableStudy completedNCT02715349
What this trial is testing

Psychoeducation for Vietnamese Families With a Patient With Schizophrenia

Who this might be right for
Schizophrenia
Danang Psychiatric Hospital 59
Not applicableStudy completedNCT00873249
What this trial is testing

Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 339
Post-approval studies (Phase 4)Study completedNCT00255515
What this trial is testing

Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 85
Large-scale testing (Phase 3)Study completedNCT01149655
What this trial is testing

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 252
Post-approval studies (Phase 4)Study completedNCT00727103
What this trial is testing

Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderAlcohol Dependence+1 more
State University of New York - Upstate Medical University 10
Not applicableStudy completedNCT01886417
What this trial is testing

Auditory Verbal Hallucinations in Schizophrenia

Who this might be right for
Schizophrenia
University Hospital, Grenoble 40
Early research (Phase 1)Study completedNCT01592110
What this trial is testing

A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Zogenix, Inc. 40
Early research (Phase 1)Study completedNCT02186769
What this trial is testing

An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Luye Pharma Group Ltd. 16
Not applicableTemporarily pausedNCT00172497
What this trial is testing

Aggressive Acts Among Patients With Schizophrenia

Who this might be right for
Schizophrenia
National Taiwan University Hospital 450
Large-scale testing (Phase 3)Study completedNCT00828958
What this trial is testing

Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53
Large-scale testing (Phase 3)Study completedNCT03893825
What this trial is testing

Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D, Inc. 336
Post-approval studies (Phase 4)Ended earlyNCT00934635
What this trial is testing

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Who this might be right for
Schizophrenia
Janssen-Cilag G.m.b.H 2
Next Page